EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (Amex:AIS) announced the signing of a feasibility and development agreement with an unnamed multi-national pharmaceutical partner for an opioid analgesic to be delivered using Antares’ proprietary EasyTec™ oral disintegrating tablet (ODT) delivery platform. EasyTec (ODT) tablets disintegrate in approximately 10 to 30 seconds with only saliva and may assist in patient compliance. EasyTec (ODT) importantly also provides an opportunity for product life cycle planning and is patented in both the U.S. and Europe. Antares will receive funding for both feasability and development activities over the course of the contract. It is anticipated that the parties will enter into an exclusive licensing arrangement upon satisfactory evaluation.
